病例报告:在CAR-T治疗后发生的罕见不良事件,这些患者患有复发性/耐药性扩散性大B细胞淋巴瘤
Ziniya Shah1, Ranju Kunwor1,2
1St Louis University School of Medicine, St. Louis, MO, United States.
Frontiers in oncology
|November 27, 2025
概括
化学抗原受体T细胞 (CAR-T) 疗法对B细胞恶性瘤具有前景. 这项研究详细介绍了在患有扩散型大B细胞淋巴瘤的患者接受CAR-T治疗后出现的三种独特,前所未有的副作用.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 化学抗原受体T细胞 (CAR-T) 疗法是B细胞恶性瘤的先进癌症治疗方法.
- 卡特-T疗法涉及对患者的T细胞进行基因改造,以向并摧毁癌细胞.
研究的目的:
- 报告在接受CAR-T治疗的患者中观察到的罕见和前所未有的不良事件.
- 为了记录与Axicabtagene ciloleucel CAR-T疗法相关的独特副作用.
主要方法:
- 三名患有复发性/耐药性扩散性大B细胞淋巴瘤的患者的病例系列.
- 患者接受了使用Axicabtagene ciloleucel的CAR-T疗法.
主要成果:
- 一名患者出现了自身免疫性脱髓化和骨髓病变.
- 另一个患者在下肢体上经历了牛皮性皮肤反应.
- 第三名患者出现了双边扩大的腺.
结论:
- 卡特-T疗法可能导致罕见且以前未经记录的不良反应.
- 这些发现凸显了对CAR-T副作用的全方位持续监测和研究的需要.
更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.7K
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
1.2K
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
